(R)-3-cyclohexyl-N-(5-(N,N-dimethylsulfamoyl)-2-methylphenyl)-2-(3-(2-(4-(trifluoromethyl)phenyl)acetyl)guanidino)propanamide Trifluoroacetic acid

ID: ALA4743293

PubChem CID: 162645390

Max Phase: Preclinical

Molecular Formula: C30H37F6N5O6S

Molecular Weight: 595.69

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)Cc1ccc(C(F)(F)F)cc1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C28H36F3N5O4S.C2HF3O2/c1-18-9-14-22(41(39,40)36(2)3)17-23(18)33-26(38)24(15-19-7-5-4-6-8-19)34-27(32)35-25(37)16-20-10-12-21(13-11-20)28(29,30)31;3-2(4,5)1(6)7/h9-14,17,19,24H,4-8,15-16H2,1-3H3,(H,33,38)(H3,32,34,35,37);(H,6,7)/t24-;/m1./s1

Standard InChI Key:  DAVZGJAQWZVCGH-GJFSDDNBSA-N

Molfile:  

     RDKit          2D

 48 49  0  0  0  0  0  0  0  0999 V2000
   17.2229  -22.9226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9348  -22.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6466  -22.9226    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.9348  -21.6927    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5111  -22.5140    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.2229  -23.7439    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.5089  -23.3312    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.5750  -20.8219    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1664  -20.1161    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.7574  -20.8193    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8831  -18.8820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8819  -19.7057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5941  -20.1188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3079  -19.7052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3051  -18.8784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5923  -18.4732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0154  -18.4672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0204  -20.1168    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7316  -19.7030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4440  -20.1146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7303  -18.8817    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1511  -19.7008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1498  -18.8795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8610  -18.4698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4415  -18.4720    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4583  -19.7046    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7502  -20.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4589  -18.8833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4453  -20.9359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1537  -21.3434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1512  -22.1640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8596  -22.5755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5732  -22.1652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5739  -21.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8610  -20.9310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5683  -18.8790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2764  -18.4711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5676  -19.6962    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.9837  -18.8804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9798  -19.6962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6863  -20.1054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3954  -19.6974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3935  -18.8760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6864  -18.4705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1032  -20.1057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1035  -20.9229    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.8108  -19.6969    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.8063  -20.5123    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  1  5  1  0
  1  6  1  0
  1  7  1  0
  9  8  2  0
 10  9  2  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 15 17  1  0
 14 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 12  9  1  0
  9 26  1  0
 26 27  1  0
 26 28  1  0
 20 29  1  6
 29 30  1  0
 30 31  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 24 36  1  0
 36 37  1  0
 36 38  2  0
 37 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 39  1  0
 42 45  1  0
 45 46  1  0
 45 47  1  0
 45 48  1  0
M  END

Associated Targets(Human)

CTSD Tchem Cathepsin D (3201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 595.69Molecular Weight (Monoisotopic): 595.2440AlogP: 4.42#Rotatable Bonds: 9
Polar Surface Area: 131.46Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.51CX Basic pKa: 7.99CX LogP: 4.86CX LogD: 4.17
Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.25Np Likeness Score: -1.27

References

1. Goyal S,Patel KV,Nagare Y,Raykar DB,Raikar SS,Dolas A,Khurana P,Cyriac R,Sarak S,Gangar M,Agarwal AK,Kulkarni A.  (2021)  Identification and structure-activity relationship studies of small molecule inhibitors of the human cathepsin D.,  29  [PMID:33271453] [10.1016/j.bmc.2020.115879]

Source